| Literature DB >> 19931009 |
Jining Zhou1, Barry Uhl, Kelly Dewitt, Mark Young, Brian Taylor, Ding-Yu Fei, Yeh-Chi Lo.
Abstract
We investigated the use of a BodyLoc immobilization and stereotactic localization device combined with TomoTherapy megavoltage CT (MVCT) in lung stereotactic body radiotherapy (SBRT) to reduce set-up uncertainty and treatment time. Eight patients treated with 3-5 fractions of SBRT were retrospectively analyzed. A BodyLoc localizer was used in both CT simulation for localization and the initial patient treatment set-up. Patients were immobilized with a vacuum cushion on the back and a thermoplastic body cast on the anterior body. Pretreatment MVCT from the TomoTherapy unit was fused with the planning kilovoltage CT (KVCT) before each fraction of treatment to determine interfractional set-up error. The comparison of two MVCTs during a fraction of treatment resulted in the intrafractional uncertainty of the treatment. A total of 224 target isocenter shifts were analyzed to assess these inter- and intrafractional tumor motions. We found that for interfractional shifts, the mean set-up errors and standard deviations were -1.1 +/- 2.8 mm, -2.5 +/- 8.7 mm, and 4.1 +/- 2.6 mm, for lateral, longitudinal, and vertical variation, respectively; the mean setup rotational variation was -0.3 +/- 0.7 degrees; and the maximum motion was 13.5 mm in the longitudinal direction. For intrafractional shifts, the mean set-up errors and standard deviations were -0.1 +/- 0.7 mm, -0.3 +/- 2.0 mm, and 0.5 +/- 1.1 mm for the lateral, longitudinal, and vertical shifts, respectively; the mean rotational variation was 0.1 +/- 0.2 degrees; and the maximum motion was 3.8 mm in the longitudinal direction. There was no correlation among patient characteristics, set-up uncertainties, and isocenter shifts, and the interfractional set-up uncertainties were larger than the intrafractional isocenter shift. The results of this study suggested that image-guided stereotactic body radiotherapy using the BodyLoc immobilization system with TomoTherapy can improve treatment accuracy. Published by Elsevier Inc.Entities:
Mesh:
Year: 2009 PMID: 19931009 DOI: 10.1016/j.meddos.2008.12.003
Source DB: PubMed Journal: Med Dosim ISSN: 1873-4022 Impact factor: 1.482